BPC
GNCA

Banque Pictet & Cie’s Genocea Biosciences, Inc. GNCA Stock Holding History

Banque Pictet & Cie’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,410
Closed -$102K – 547
2014
Q3 		$102K Sell
1,410
-41
-3% -$4.49K ﹤0.01% 452
2014
Q2 		$218K Buy
+1,451
New +$220K 0.01% 415

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Banque Pictet & Cie's GNCA Position: Q4 2014 in Review

Banque Pictet & Cie sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2014, closing a stake of 1,410 shares — an estimated $102K sold.

Banque Pictet & Cie first reported a position in GNCA in Q2 2014 and held it in 2 quarters. The position peaked at $218K in Q2 2014. 38 funds tracked by Wall St. Rank hold GNCA as of Q4 2014.

  • Banque Pictet & Cie reported no remaining Genocea Biosciences, Inc. position as of Q4 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 1,410 Genocea Biosciences, Inc. shares in Q4 2014, an estimated $102K.
  • Banque Pictet & Cie first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 2 quarters.
  • Banque Pictet & Cie's Genocea Biosciences, Inc. position peaked at $218K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2014.

Based on Banque Pictet & Cie's 13F filing for Q4 2014, filed 12 Feb 2015.